ReleaseWire Connect

This report on the non-small cell lung cancer (NSCLC) Therapeutics market studies the current and future prospects of the global market. Non-small cell lung cancer is a type of lung cancer which accounted 85-90% of all lung cancers. There are three major subtypes of NSCLC namely squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. NSCLC is relatively insensitive to chemotherapy compared to small cell lung cancer. Increasing awareness along with incidence rate are expected to propel the global non-small cell lung cancer therapeutics market.

This report on the breast cancer therapeutics market studies the current as well as future prospects of the market globally. The stakeholders of this report include pharmaceutical companies and intermediaries engaged in the new drug discovery, pipeline development of various breast cancer therapeutics as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global breast cancer therapeutics market with respect to the leading market segments in terms of geography.

This report on the primary immunodeficiency diseases (PIDD) market studies the current as well as future prospects of the market. The stakeholders of this report include pharmaceuticals companies, diagnostic kits providers, distributors, care providers and insurance companies (payers) and other intermediaries engaged in PIDD as well as new entrants that are planning to enter in this segment. This report comprises an elaborate executive summary with a market snapshot providing overall information of various segments and sub-segments considered in the study scope. The executive summary also provides overall information and data analysis of the PIDD market with respect to the leading market segments based on Disease, Test, Treatment and Geography. The market revenue in terms of USD million for the period between 2013 and 2023 along with the compound annual growth rate (CAGR %) from 2015 to 2023 are provided for all segments and sub-segments considered under the scope of study, considering 2014 as the base year. Pipeline analysis (qualitative) for Phase I, II candidates whereas a detailed quantitative aspect (US$ Mn) for III drugs are illustrated in the market overview chapter.

This report covers the analysis and forecast of the fluorspar market on the global and regional level. The study provides historic data of 2014 along with forecast between 2015 and 2023 based on volume (kilo tons) and revenue (US$ Mn).

Dicyclopentadiene (DCPD) is obtained from the high temperature cracking of petroleum products and is best characterized by its usage as a highly reactive intermediate in the manufacture of numerous resins - aromatic hydrocarbons, phenolics, unsaturated polyesters, and epoxies.

Polypropylene is a thermoplastic polymer that can be readily formed by catalytic polymerization of propylene. Manufacture of polypropylene is largely dependent on the availability of raw materials. This, in turn, is dependent on crude oil and natural gas reserves. Polypropylene possesses beneficial properties such as high surface hardness, good tensile strength, and strong chemical resistance. As a result, it has gradually replaced other polyolefins in several applications. It is one of the most versatile polymers used in packaging, automobile, construction, electrical & electronics, and medical industries. Rising demand for polypropylene in the packaging industry is likely to augment the global polypropylene market in the next few years. Additionally, rising demand for lightweight vehicles is expected to drive growth of the polypropylene market during the forecast period. However, growing environmental issues and volatile raw material prices are projected to hamper growth of the market during the forecast period. Biobased polypropylene is likely to offer immense opportunities to polypropylene manufacturers from 2015 to 2023.

Rising demand from packaging and healthcare industries coupled with technological developments are expected to drive the polypropylene random copolymer market between 2015 and 2023. Polypropylene random copolymer is primarily used in the manufacture of food containers due to high heat and impact resistance, flexibility, and excellent transparency. Furthermore, capacity additions in the Middle East and China are anticipated to boost the market growth. There is significant demand for food containers in Asia Pacific due to changing lifestyle and shift toward processed and packaged food However, availability of substitutes such as polyethylene, polystyrene, polycarbonate, polyethylene terephthalate, and other polyolefins is anticipated to hamper growth of the global polypropylene random copolymer market during the forecast period. The beverages industry is likely to offer large opportunities for polypropylene random copolymer manufacturers from 2015 to 2023.

This report on the testing and analysis services market studies the current as well as future prospects of the market. The stakeholders of this report include testing and analysis companies catering to Pharmaceutical, biomedical, petroleum, energy, food and beverages, mining, metal, and other heavy industry. In addition, the report also include extensive coverage of instruments for testing services which may help equipment firms to understand this market form consumer prospective.

Hypertrophic cardiomyopathy (HCM) is a disease of the heart muscles (myocardium) in which thickening of myocardium causes functional impairment. It is a genetic condition caused by mutation in one or more genes and is hereditary in nature. According to the European Society of Cardiology, prevalence of HCM was between 0.05% and 0.2% of the population in 2013. A study published in BioMed Central in 2010 stated that there was no significant gender and age range differences in the prevalence of HCM. Prevalence of HCM is higher among African-Americans compared to other races. The global hypertrophic cardiomyopathy therapeutics market was valued at USD 1,216.3 million in 2014 and is projected to reach USD 1,378.4 million by 2023, expanding at a CAGR of 1.4% during the forecast period.

Pipeline analysis of spinal muscular atrophy (SMA) market report provides with comprehensive analysis of drugs in clinical trials for treatment for spinal muscular atrophy. The report provides insights to SMA prevalence, and current treatment pattern. The report also identifies key market drivers, restraints and opportunities in the global spinal muscular atrophy therapeutics market. Detailed market attractiveness analysis by geography provides future outlook to the spinal muscular atrophy landscape. Market attractiveness analysis considers various factors such as patient population, drug pricing policies, regulatory restrictions, current competition intensity, and current state of healthcare sector for assessing the potential of each geographical market.